R. Kirk Huntsman

2023

In 2023, R. Kirk Huntsman earned a total compensation of $657.7K as Chief Executive Officer at Vivos Therapeutics, a 30% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$175,543
Salary$463,393
Other$18,765
Total$657,701
70.46%

Huntsman received $463.4K in salary, accounting for 70% of the total pay in 2023.

Huntsman also received $175.5K of change in pension value and nonqualified deferred compensation earnings and $18.8K in other compensation.

Rankings

In 2023, R. Kirk Huntsman's compensation ranked 1,703rd out of 2,990 executives tracked by ExecPay. In other words, Huntsman earned more than 43.0% of executives.

ClassificationRankingPercentile
All
1,703
out of 2,990
43rd
Division
Manufacturing
993
out of 1,640
40th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
133
out of 256
48th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
90
out of 188
52nd
Industry
Surgical and Medical Instruments and Apparatus
76
out of 144
47th
Source: SEC filing on October 7, 2024.

Huntsman's colleagues

We found one more compensation record of an executive who worked with R. Kirk Huntsman at Vivos Therapeutics in 2023.

2023

Bradford Amman

Vivos Therapeutics

Chief Financial Officer

News

You may also like